Royal Fund Management, LLC Spdr Ser Tr Spdr S&P Biotech E Transaction History

Royal Fund Management, LLC

$979 Million
Q2 2025

A detailed history of Royal Fund Management, LLC transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Royal Fund Management, LLC holds 67,521 shares of XBI stock, worth $5.77 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares

67,521

Previous 63,313 6.65%

Holding current value

$5.77 Million

Previous $5.13 Million 9.06%

% of portfolio

0.57%

Previous 0.58%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$69.8 - $85.28 $293,718 - $358,858	4,208 Added 6.65%	67,521 $5.6 Million
Q1 2025 May 14, 2025	BUY	$81.1 - $94.7 $57,824 - $67,521	713 Added 1.14%	63,313 $5.13 Million
Q4 2024 Jan 16, 2025	SELL	$89.81 - $104.0 $21 Million - $24.3 Million	-233,886 Reduced 78.89%	62,600 $5.64 Million
Q3 2024 Oct 08, 2024	BUY	$90.87 - $102.43 $21.4 Million - $24.2 Million	235,835 Added 388.84%	296,486 $29.3 Million
Q2 2024 Jul 18, 2024	BUY	$82.22 - $94.12 $4.99 Million - $5.71 Million	60,651 New	60,651 $5.62 Million
Q1 2018 May 07, 2020	SELL	N/A	-102 Closed	0 $0
Q4 2017 May 07, 2020	BUY	N/A	102	102 $8,000

Others Institutions Holding XBI

# of Institutions

801

Shares Held

111M

Call Options Held

22.4M

Put Options Held

28.8M

View Full List

About SPDR SER TR SPDR S&P BIOTECH E

Ticker XBI
Sector ETFs
Industry ETFs

More about XBI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Royal Fund Management, LLC with notifications on news.

Account

Royal Fund Management, LLC Spdr Ser Tr Spdr S&P Biotech E Transaction History